FBCM
BBOT

Fort Baker Capital Management’s BridgeBio Oncology BBOT Stock Holding History

Fort Baker Capital Management’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-374,683
Closed -$4.23M – 78
2025
Q1 		$4.23M Buy
+374,683
New +$4.03M 0.87% 33

Other funds holding BBOT

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HCI
Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return

Fort Baker Capital Management's BBOT Position: Q2 2025 in Review

Fort Baker Capital Management sold out of BridgeBio Oncology (BBOT) in Q2 2025, closing a stake of 374,683 shares — an estimated $4.23M sold.

Fort Baker Capital Management first reported a position in BBOT in Q1 2025 and held it in 1 quarter. The position peaked at $4.23M in Q1 2025. 34 funds tracked by Wall St. Rank hold BBOT as of Q2 2025.

  • Fort Baker Capital Management reported no remaining BridgeBio Oncology position as of Q2 2025 after selling out during the quarter.
  • Fort Baker Capital Management sold 374,683 BridgeBio Oncology shares in Q2 2025, an estimated $4.23M.
  • Fort Baker Capital Management first reported a position in BridgeBio Oncology in Q1 2025 and held it in 1 quarter.
  • Fort Baker Capital Management's BridgeBio Oncology position peaked at $4.23M in Q1 2025.
  • 34 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q2 2025.

Based on Fort Baker Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.